Great West Life Assurance CO Intellia Therapeutics, Inc. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 25,464 shares of NTLA stock, worth $304,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,464
Previous 25,981 1.99%
Holding current value
$304,804
Previous $582,000 9.97%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$19.72 - $27.36 $10,195 - $14,145
-517 Reduced 1.99%
25,464 $524,000
Q2 2024

Aug 12, 2024
SELL
$20.02 - $27.22 $32,632 - $44,368
-1,630 Reduced 5.9%
25,981 $582,000
Q1 2024

May 13, 2024
BUY
$23.82 - $32.8 $7,860 - $10,823
330 Added 1.21%
27,611 $759,000
Q4 2023

Feb 13, 2024
BUY
$23.16 - $32.34 $84,117 - $117,458
3,632 Added 15.36%
27,281 $826,000
Q3 2023

Nov 14, 2023
BUY
$31.62 - $45.78 $176,819 - $256,001
5,592 Added 30.97%
23,649 $747,000
Q2 2023

Aug 10, 2023
SELL
$34.58 - $46.03 $39,767 - $52,934
-1,150 Reduced 5.99%
18,057 $741,000
Q1 2023

May 12, 2023
BUY
$33.3 - $44.82 $116,483 - $156,780
3,498 Added 22.27%
19,207 $717,000
Q4 2022

Feb 10, 2023
BUY
$33.21 - $62.69 $204,374 - $385,794
6,154 Added 64.41%
15,709 $551,000
Q3 2022

Nov 01, 2022
BUY
$53.92 - $71.7 $515,205 - $685,093
9,555 New
9,555 $534,000
Q2 2022

Aug 09, 2022
BUY
$38.49 - $76.21 $1,385 - $2,743
36 Added 1.05%
3,453 $178,000
Q1 2022

May 12, 2022
SELL
$58.27 - $118.99 $2,097 - $4,283
-36 Reduced 1.04%
3,417 $264,000
Q4 2021

Feb 14, 2022
BUY
$100.76 - $138.36 $3,325 - $4,565
33 Added 0.96%
3,453 $407,000
Q2 2021

Aug 11, 2021
BUY
$60.88 - $161.91 $32,449 - $86,298
533 Added 18.46%
3,420 $553,000
Q1 2021

May 17, 2021
SELL
$46.59 - $83.68 $24,413 - $43,848
-524 Reduced 15.36%
2,887 $230,000
Q4 2020

Feb 16, 2021
BUY
$18.83 - $63.53 $19,263 - $64,991
1,023 Added 42.84%
3,411 $185,000
Q4 2019

Feb 11, 2020
BUY
$10.43 - $17.67 $24,906 - $42,195
2,388 New
2,388 $35,000
Q3 2019

Oct 25, 2019
SELL
$13.07 - $18.51 $58,815 - $83,295
-4,500 Closed
0 $0
Q4 2018

Feb 12, 2019
SELL
$11.39 - $27.13 $462,547 - $1.1 Million
-40,610 Reduced 90.02%
4,500 $59,000
Q3 2018

Nov 13, 2018
SELL
$25.78 - $32.6 $1.34 Million - $1.69 Million
-51,921 Reduced 53.51%
45,110 $1.3 Million
Q2 2018

Aug 10, 2018
BUY
$20.02 - $30.79 $47,947 - $73,742
2,395 Added 2.53%
97,031 $2.65 Million
Q1 2018

May 10, 2018
BUY
$19.43 - $34.95 $1.81 Million - $3.26 Million
93,236 Added 6659.71%
94,636 $2 Million
Q3 2017

Nov 09, 2017
BUY
$15.16 - $25.75 $21,224 - $36,050
1,400
1,400 $34,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $910M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email